Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy (QCA) and Safety of the BioFreedom™ Ultra Drug Coated Stent in Patients With High Bleeding Risk and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

NCT06657326 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT06657326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy (QCA) and Safety of the BioFreedom™ Ultra Drug Coated Stent in Patients With High Bleeding Risk and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Lead sponsor
Biosensors Europe SA
Phase
Not applicable
Overall status
Recruiting
Start date
December 18, 2024
Completion date
December 31, 2030
Enrollment
444 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, chronic stable angina, coronary artery disease, silent ischemia, unstable angina